Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
Explore this paper's citation graph
Summary
It is recommended that the term renal osteodystrophy be used exclusively to define alterations in bone morphology associated with CKD, and the term CKD-Mineral and Bone Disorder (CKD-MBD) be used to describe a broader clinical syndrome that develops as a systemic disorder of mineral and bone metabolism due to CKD.
- Type
- article
- Published
- 2006-06-01
- Cited by
- 1,973
- References
- 38
- Access
- Open access
- OpenAlex
- https://openalex.org/W2172159264
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:10715845
Keywords
Renal osteodystrophy, Position statement, Medicine, Kidney disease, Intensive care medicine
References
- VITAMIN D IN HEALTH AND DISEASE: The Evolution of Assays for Parathyroid Hormone
- Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
- A bridge to improving healthcare outcomes and quality of life.
- New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study.
- The association of nephrolithiasis with cystic fibrosis.
- Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures.
- Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure.
- Circulating biochemical markers of bone remodeling in uremic patients.
- The spectrum of bone disease in end-stage renal failure--an evolving disorder.
- Diagnostic and prognostic value of coronary artery calcium screening
- The burden of kidney disease: improving global outcomes.
- Calcification and cardiovascular problems in renal failure.
- Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.
- Bone metabolism and disease in chronic kidney disease
- Fetuin-A and extraosseous calcification in uremia
- Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia
- Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
- Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.
- Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
- Percutaneous bone biopsy in the diagnosis of renal osteodystrophy.
Cited by
- CE: Continuing Education article. Patient management in chronic kidney disease stages 4 to 5.
- Opinion: When is Vitamin D Contraindicated in Dialysis Patients?
- Age-independent association between arterial and bone remodeling in mild-to-moderate chronic kidney disease.
- Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.
- Fragility fractures in chronic kidney disease: An opinion-based approach
- Association of Serum Alkaline Phosphatase and Bone Mineral Density in Maintenance Hemodialysis Patients
- The Bone Histology Spectrum in Experimental Renal Failure: Adverse Effects of Phosphate and Parathyroid Hormone Disturbances
- Value of the new bone classification system in pediatric renal osteodystrophy.
- Parathyroid gland regulation: contribution of the in vivo and in vitro models
- Skeletal effects of zoledronic acid in an animal model of chronic kidney disease
- Parathyroid hormone targets in chronic kidney disease and managing severe hyperparathyroidism
- Circulating markers of bone turnover
- Vascular Damage and Kidney Transplant Outcomes: An Unfriendly and Harmful Link
- Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption
- Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
- Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry.
- Parathyroidectomy in dialysis patients: Indications, methods, and consequences
- 透析液カルシウム濃度3.0mEq/Lから2.75mEq/Lへの変更は血清PTH濃度に影響しない
- Vascular calcifications in chronic kidney disease--clinical management.
- Bone histomorphometry revisited.
Related papers
- Renal Osteodystrophy
- Hypohyperparathyroidism: a model for renal osteodystrophy?
- Cell biology of renal osteodystrophy
- [Chronic kidney disease (CKD) and bone. From renal osteodystrophy to CKD-MBD: new disease entity].
- An Update to the Society for Adolescent Health and Medicine's Position Statement on the Human Papillomavirus Vaccine
- Early Origins of Cardiovascular Disease in Pediatric Chronic Kidney Disease
- Meeting the challenges of the new K/DOQI guidelines.